Literature DB >> 34141072

Versatile Target-Guided Screen for Discovering Bidirectional Transcription Inhibitors of a Trinucleotide Repeat Disease.

Lauren D Hagler1, Sarah B Krueger1, Long M Luu1, Amie N Lanzendorf1, Niya L Mitchell1, J Ignacio Vergara1, L Daniel Curet1, Steven C Zimmerman1.   

Abstract

Myotonic dystrophy type 1 originates from d(CTG·CAG) repeats that undergo aberrant expansion during normal processing because the d(CTG) repeat forms stable hairpin structures. Bidirectional transcription of d(CTG·CAG) yields two RNA transcripts that undergo repeat-associated non-ATG (RAN) translation to form homopolymeric proteins. Thus, both the r(CUG) transcript and the r(CAG) transcript are known to be toxic. We report a pairwise fragment-based, target-guided approach to screen for proximity-induced click dimers formed on the nucleic acid template. This screen uses an azide/alkyne clickable fragment library of nucleic acid-binding ligands incubated in parallel, pairwise reactions as an alternative to our previously reported one-pot screening method. MALDI-TOF mass spectroscopy was used to detect template assisted click products. Hit compounds inhibited the in vitro transcription of d(CTG·CAG)90 bidirectionally with IC50 values in the low micromolar range. This approach may be broadly applicable to other trinucleotide repeat diseases and in targeting other disease-associated nucleic acid sequences.
© 2021 American Chemical Society.

Entities:  

Year:  2021        PMID: 34141072      PMCID: PMC8201509          DOI: 10.1021/acsmedchemlett.1c00064

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.632


  30 in total

Review 1.  Transcription factors as targets for DNA-interacting drugs.

Authors:  Marek Gniazdowski; William A Denny; Stephanie M Nelson; Malgorzata Czyz
Journal:  Curr Med Chem       Date:  2003-06       Impact factor: 4.530

Review 2.  Long non‑coding RNAs: novel links in respiratory diseases (review).

Authors:  Yanru Liu; Ruifeng Zhang; Kejing Ying
Journal:  Mol Med Rep       Date:  2015-01-30       Impact factor: 2.952

3.  Driving factors in amiloride recognition of HIV RNA targets.

Authors:  Neeraj N Patwardhan; Zhengguo Cai; Aline Umuhire Juru; Amanda E Hargrove
Journal:  Org Biomol Chem       Date:  2019-10-30       Impact factor: 3.876

4.  Intrinsically cell-penetrating multivalent and multitargeting ligands for myotonic dystrophy type 1.

Authors:  JuYeon Lee; Yugang Bai; Ullas V Chembazhi; Shaohong Peng; Kevin Yum; Long M Luu; Lauren D Hagler; Julio F Serrano; H Y Edwin Chan; Auinash Kalsotra; Steven C Zimmerman
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-11       Impact factor: 11.205

Review 5.  Partners in crime: bidirectional transcription in unstable microsatellite disease.

Authors:  Ranjan Batra; Konstantinos Charizanis; Maurice S Swanson
Journal:  Hum Mol Genet       Date:  2010-04-04       Impact factor: 6.150

Review 6.  Along the Central Dogma-Controlling Gene Expression with Small Molecules.

Authors:  Tilman Schneider-Poetsch; Minoru Yoshida
Journal:  Annu Rev Biochem       Date:  2018-05-04       Impact factor: 23.643

Review 7.  Triptolide and its expanding multiple pharmacological functions.

Authors:  Qiuyan Liu
Journal:  Int Immunopharmacol       Date:  2011-01-19       Impact factor: 4.932

8.  Molecular Glue for RNA: Regulating RNA Structure and Function through Synthetic RNA Binding Molecules.

Authors:  Chikara Dohno; Kazuhiko Nakatani
Journal:  Chembiochem       Date:  2019-09-20       Impact factor: 3.164

9.  Inhibitors of protein-RNA complexation that target the RNA: specific recognition of human immunodeficiency virus type 1 TAR RNA by small organic molecules.

Authors:  H Y Mei; M Cui; A Heldsinger; S M Lemrow; J A Loo; K A Sannes-Lowery; L Sharmeen; A W Czarnik
Journal:  Biochemistry       Date:  1998-10-06       Impact factor: 3.162

10.  Developmental dynamics of lncRNAs across mammalian organs and species.

Authors:  Margarida Cardoso-Moreira; Henrik Kaessmann; Ioannis Sarropoulos; Ray Marin
Journal:  Nature       Date:  2019-06-26       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.